FDA approval for Allergan's intraocular lens:
This article was originally published in Clinica
Executive Summary
The FDA has given Allergan the go-ahead to market its Sensar foldable acrylic posterior chamber intraocular lens (IOL) in the US. The product is a next-generation acrylic IOL designed to minimise some of the unwanted side effect associated with current acrylic lenses, said the Irvine, California-based company. The new IOL is delivered into the eye using the company's implantation system called The Unfolder.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.